Innovative strategies for co-delivering antigens and CpG oligonucleotides.
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesImmunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposureNanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MITContrasting roles for TLR ligands in HIV-1 pathogenesis.pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.Enhancing mucosal immunity in mice by recombinant adenovirus expressing major epitopes of porcine circovirus-2 capsid protein delivered with cytosine-phosphate-guanosine oligodeoxynucleotidesLiposomes as vaccine delivery systems: a review of the recent advances.Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccinesImmunostimulatory sutures that treat local disease recurrence following primary tumor resectionA CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanismsVirus-like nanostructures for tuning immune response.Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.Biodegradable particles as vaccine delivery systems: size mattersNanoparticle delivery systems in cancer vaccines.Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticlesEncapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity.A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.A DNA nanostructure platform for directed assembly of synthetic vaccinesRational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cellsTumor lysate-loaded biodegradable microparticles as cancer vaccines.Drug delivery systems for differential release in combination therapy.Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses.Applying biodegradable particles to enhance cancer vaccine efficacy.Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.Membrane anchored immunostimulatory oligonucleotides for in vivo cell modification and localized immunotherapy.Syntheses and biomedical applications of hollow micro-/nano-spheres with large-through-holes.Biomimetic nanoassembly for targeted antigen delivery and enhanced Th1-type immune response.Combination delivery of antigens and CpG by lanthanides-based core-shell nanoparticles for enhanced immune response and dual-mode imaging.Delivery system for the enhanced efficiency of immunostimulatory nucleic acids.Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.Intracellular Cleavable CpG Oligodeoxynucleotide-Antigen Conjugate Enhances Anti-tumor Immunity.Polymeric microspheres as protein transduction reagents.Immune response to recombinant Leishmania infantum lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB/c mice.Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses.Nanoparticles in vaccine delivery.Oral delivery of siRNA and antisense oligonucleotides.
P2860
Q24624348-BEEA7BBB-263A-47D7-9BA6-36E30E8FFCDDQ28077290-BF53FEB0-F5F0-4A88-8E82-83D648069998Q28471815-EE100EFC-396F-4C71-AFE4-054AB699C622Q28831253-88466EB7-71D3-4D02-B50F-ABB6286633CEQ33700312-A6B0529E-F836-48CD-819A-0D3B5E519936Q33703757-DC42145A-0111-4DD8-906D-B557D4684ED4Q34258568-39685145-4015-498C-B4D8-6073BAE0925CQ34418761-33B43F39-CF98-49C7-B51F-2B9AF1E25E6FQ34586673-D377122E-9E1F-4649-AD8F-39EE9D77B6F8Q35100779-BCD09DB6-B64F-492C-8EF2-E3092CF895E6Q35141686-8120CC4D-8889-4A62-A6E9-34F3ECBE3BC5Q35853440-AD2E8BC2-0C31-467F-8FC3-73C639D35E94Q35895400-85719697-F0AF-48B2-844F-532B714B2C29Q36291687-722A9E20-2DAF-4909-8B24-0D1F096D7709Q36396099-EE388953-2E32-4C6C-A8E7-9EBC7898A4DEQ36502434-D2A75FF4-F700-4A0C-A559-773CD6B54A38Q36574571-2C885226-98AA-4AB1-9807-D931DF7000DDQ36582010-762B6740-E8B4-4DB0-9C69-20C7929E0FEFQ37069845-0312C395-0E0D-4061-9005-F6ABA06F3A79Q37130755-53B6619E-80F0-4711-A8DE-588FEFE96EA3Q37141141-CE7522C1-28D0-4A35-B743-D6FB39E30167Q37257038-A4484FA5-4705-484F-B886-DDAA01108E07Q37601026-5E1C8B46-945A-437E-8397-C99E8F467EA5Q37670779-B39D94EB-3252-4183-B555-040AA049735CQ37827881-D4C402BF-C415-464E-9E95-96980AAE2A5EQ38131659-890170D1-04BB-4AE8-88C2-7992D7059FFAQ38212549-A2E04BAA-F73A-4FE4-BD3A-A5DC5CAAB0A7Q38285751-3E7B3ABF-8E18-4520-892B-C10A6E227926Q38300025-983AFD7C-0F90-4F38-9034-C66AFBE7A47EQ38666898-088A329A-8A13-41A7-A21C-C02CC8CC3440Q38834398-D543958B-BB54-4031-A73B-E6387EE7AF6EQ39176137-A024180E-FB9F-4DE9-B649-B5A9271255C3Q39325348-D694B950-C05C-428E-ACD5-F34AE56EE0E1Q39985946-97DBB027-F7AB-4287-B90F-A63B9CC0BC8FQ40361898-19B9A04A-89B5-4326-8EE5-008C19AD4A19Q40373344-CA318412-162B-4022-BC0C-F2B3EC9678AEQ40633289-78ABB736-22D1-44A7-ACB0-E38CCE052689Q40700979-14E0AF1C-EC25-4E6B-8391-AAB5064CAEBCQ42558664-FC1E99DF-17BE-4599-A992-63D7CCF20967Q45896502-BE35F4AF-F2D0-41E0-A454-C90FDB819D0F
P2860
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@en
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@nl
type
label
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@en
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@nl
prefLabel
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@en
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@nl
P2860
P1476
Innovative strategies for co-delivering antigens and CpG oligonucleotides.
@en
P2093
Aliasger K Salem
Yogita Krishnamachari
P2860
P304
P356
10.1016/J.ADDR.2008.12.013
P407
P577
2009-01-19T00:00:00Z